ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02169557
Recruitment Status : Unknown
Verified October 2016 by Drugs for Neglected Diseases.
Recruitment status was:  Active, not recruiting
First Posted : June 23, 2014
Last Update Posted : October 7, 2016
Sponsor:
Information provided by (Responsible Party):
Drugs for Neglected Diseases

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2016
  Estimated Study Completion Date : April 2017